Sun Pharmaceutical Industries Limited (NSEI:SUNPHARMA) is reportedly seeking to sell its US subsidiary, Ohm Laboratories, Inc., as it looks to consolidate its operations in its biggest overseas market, according to a television report. The US market accounts for about half of the drug maker's consolidated revenue but the business is under pressure because of price erosion and regulatory issues. A Sun Pharma spokesperson declined comment. A television report said the sale could fetch $80-$100 million.